BACKGROUND: Cigarette smoke contains compounds that may damage DNA, and the repair of damage may be impaired in women with germline mutations in BRCA1 or BRCA2. However, the effect of cigarette smoking on breast cancer risk in mutation carriers is the subject of conflicting reports. We have examined the relation between smoking and breast cancer risk in non-Hispanic white women under the age of 50 years who carry a deleterious mutation in BRCA1 or BRCA2. METHODS: We conducted a case-control study using data from carriers of mutations in BRCA1 (195 cases and 302 controls) and BRCA2 (128 cases and 179 controls). Personal information, including smoking history, was collected using a common structured questionnaire by eight recruitment sites in four countries. Odds-ratios (OR) for breast cancer risk according to smoking were adjusted for age, family history, parity, alcohol use, and recruitment site. RESULTS: Compared to non-smokers, the OR for risk of breast cancer for women with five or more pack-years of smoking was 2.3 (95% confidence interval 1.6-3.5) for BRCA1 carriers and 2.6 (1.8-3.9) for BRCA2 carriers. Risk increased 7% per pack-year (p<0.001) in both groups. CONCLUSIONS: These results indicate that smoking is associated with increased risk of breast cancer before age 50 years in BRCA1 and BRCA2 mutation carriers. If confirmed, they provide a practical way for carriers to reduce their risks. Previous studies in prevalent mutation carriers have not shown smoking to increase risk of breast cancer, but are subject to bias, because smoking decreases survival after breast cancer.
BACKGROUND: Cigarette smoke contains compounds that may damage DNA, and the repair of damage may be impaired in women with germline mutations in BRCA1 or BRCA2. However, the effect of cigarette smoking on breast cancer risk in mutation carriers is the subject of conflicting reports. We have examined the relation between smoking and breast cancer risk in non-Hispanic white women under the age of 50 years who carry a deleterious mutation in BRCA1 or BRCA2. METHODS: We conducted a case-control study using data from carriers of mutations in BRCA1 (195 cases and 302 controls) and BRCA2 (128 cases and 179 controls). Personal information, including smoking history, was collected using a common structured questionnaire by eight recruitment sites in four countries. Odds-ratios (OR) for breast cancer risk according to smoking were adjusted for age, family history, parity, alcohol use, and recruitment site. RESULTS: Compared to non-smokers, the OR for risk of breast cancer for women with five or more pack-years of smoking was 2.3 (95% confidence interval 1.6-3.5) for BRCA1 carriers and 2.6 (1.8-3.9) for BRCA2 carriers. Risk increased 7% per pack-year (p<0.001) in both groups. CONCLUSIONS: These results indicate that smoking is associated with increased risk of breast cancer before age 50 years in BRCA1 and BRCA2 mutation carriers. If confirmed, they provide a practical way for carriers to reduce their risks. Previous studies in prevalent mutation carriers have not shown smoking to increase risk of breast cancer, but are subject to bias, because smoking decreases survival after breast cancer.
Authors: Robert W Haile; Duncan C Thomas; Valerie McGuire; Anna Felberg; Esther M John; Roger L Milne; John L Hopper; Mark A Jenkins; A Joan Levine; Mary M Daly; Saundra S Buys; Ruby T Senie; Irene L Andrulis; Julia A Knight; Andrew K Godwin; Melissa Southey; Margaret R E McCredie; Graham G Giles; Lesley Andrews; Katherine Tucker; Alexander Miron; Carmel Apicella; Andrea Tesoriero; Anita Bane; Malcolm C Pike; Alice S Whittemore Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-10-04 Impact factor: 4.254
Authors: Wael K Al-Delaimy; Eunyoung Cho; Wendy Y Chen; Graham Colditz; Walter C Willet Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-03 Impact factor: 4.254
Authors: S M Lesko; L Rosenberg; D W Kaufman; S P Helmrich; D R Miller; B Strom; D Schottenfeld; N B Rosenshein; R C Knapp; J Lewis Journal: N Engl J Med Date: 1985-09-05 Impact factor: 91.245
Authors: Esther M John; John L Hopper; Jeanne C Beck; Julia A Knight; Susan L Neuhausen; Ruby T Senie; Argyrios Ziogas; Irene L Andrulis; Hoda Anton-Culver; Norman Boyd; Saundra S Buys; Mary B Daly; Frances P O'Malley; Regina M Santella; Melissa C Southey; Vickie L Venne; Deon J Venter; Dee W West; Alice S Whittemore; Daniela Seminara Journal: Breast Cancer Res Date: 2004-05-19 Impact factor: 6.466
Authors: Mala Pande; Patrick M Lynch; John L Hopper; Mark A Jenkins; Steve Gallinger; Robert W Haile; Loic LeMarchand; Noralane M Lindor; Peter T Campbell; Polly A Newcomb; John D Potter; John A Baron; Marsha L Frazier; Christopher I Amos Journal: Clin Cancer Res Date: 2010-02-09 Impact factor: 12.531
Authors: Ourania Kosti; Celia Byrne; Katherine L Meeker; Kenshata M Watkins; Christopher A Loffredo; Peter G Shields; Marc D Schwartz; Shawna C Willey; Costanza Cocilovo; Yun-Ling Zheng Journal: Carcinogenesis Date: 2010-01-28 Impact factor: 4.944
Authors: M B Terry; C A Schaefer; J D Flom; Y Wei; P Tehranifar; Y Liao; S Buka; K B Michels Journal: J Dev Orig Health Dis Date: 2011-12 Impact factor: 2.401
Authors: Susan L Neuhausen; Hilmi Ozcelik; Melissa C Southey; Esther M John; Andrew K Godwin; Wendy Chung; Jeniffer Iriondo-Perez; Alexander Miron; Regina M Santella; Alice Whittemore; Irene L Andrulis; Saundra S Buys; Mary B Daly; John L Hopper; Daniela Seminara; Ruby T Senie; Mary Beth Terry Journal: Breast Cancer Res Treat Date: 2008-08-14 Impact factor: 4.872
Authors: Ophira Ginsburg; Parviz Ghadirian; Jan Lubinski; Cezary Cybulski; Henry Lynch; Susan Neuhausen; Charmaine Kim-Sing; Mark Robson; Susan Domchek; Claudine Isaacs; Jan Klijn; Susan Armel; William D Foulkes; Nadine Tung; Pal Moller; Ping Sun; Steven A Narod Journal: Breast Cancer Res Treat Date: 2008-05-16 Impact factor: 4.872